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Abstract
Background: Short-term kidney graft dysfunction is correlated with complications and it is 
associated with a decreased long-term survival; therefore, a scoring system to predict short-
term renal transplant outcomes is warranted. Aim: The aim of this study is to quantify the 
impression of the organ procurement surgeon in correlation with the following kidney trans-
plant outcomes: immediate graft function (IGF), delayed graft function (DGF), and primary 
nonfunction (PNF). Results are compared to factors associated with the 1-year outcome. 
Methods: A regional prospective pilot study was performed using deceased-donor organ as-
sessment forms to be filled out by procurement surgeons after procurement. Data were gath-
ered on kidney temperature, perfusion, anatomy, atherosclerosis, and overall quality. Results: 
Included were 90 donors who donated 178 kidneys, 166 of which were transplanted. Variables 
that were significantly more prevalent in the DGF-or-PNF group (n = 65) are: large kidney size 
(length, p = 0.008; width, p = 0.036), poor perfusion quality (p = 0.037), lower diuresis 
(p = 0.039), fewer hypotensive episodes (p = 0.003), and donation-after-circulatory-death do-
nors (p = 0.017). Multivariable analysis showed that perfusion quality and kidney width sig-
nificantly predicted the short-term outcome. However multivariable analysis of long-term 
outcomes showed that the first measured donor creatinine, kidney donor risk index, IGF vs. 
DGF+PNG, and kidney length predicted outcomes. Conclusions: Results show that short-term 
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graft function and 1-year graft function indeed are influenced by different variables. DGF and 
PNF occur more frequently in kidneys with poor perfusion and in larger kidneys. A plausible 
explanation for this is that these kidneys might be insufficiently washed out, or even congest-
ed, which may predispose to DGF. These kidneys would probably benefit most from recondi-
tioning strategies, such as machine perfusion. A scoring system including these variables 
might aid in decision-making towards allocation and potential reconditioning strategies.
© 2019 The Author(s) 
Published by S. Karger AG, Basel
IntroductionCurrently there are various methods, i.e., the deceased-donor score, the donor risk score, and the kidney donor risk index (KDRI), for pretransplant quality assessment of donor organs. These methods consist of donor, recipient, and donation procedure characteristics [1, 2]. Apart from renal artery plaque in the deceased-donor score, none of these assessments includes surgical and anatomical variables available during procurement (procurement surgeon’s assessment of an organ).Although eventually long-term graft survival is the aim, short-term dysfunction is asso-ciated with morbidity and mortality associated with the presence of a nonfunctioning graft in an immunosuppressed patient. DGF is associated with a reduced graft survival [3–7], although some studies have found an unimpaired long-term graft survival [4, 6]. DGF is also associated with increased comorbidity and mortality in the direct postoperative phase and with increased costs [4, 7]. After a deceased-donor kidney transplantation, 21–52% of recipients have delayed graft function (DGF) and 48–69% have immediate graft function (IGF) [5, 6, 8]. A small percentage (0.6–8%) of transplanted kidneys will never function [9].This study attempts to quantify the surgeon’s subjective detailed impression of organ quality and to correlate this to the following transplant outcomes: IGF, DGF, and primary nonfunction (PNF). A scoring system to predict short-term renal transplant outcomes incor-porating these surgical details might aid in decision-making towards acceptance and potential reconditioning strategies.
Materials and MethodsBetween 2014 and 2016, we performed a prospective regional pilot study in which procurement surgeons were asked to participate. A detailed organ assessment form (scoring system) was developed to be filled out by the procurement surgeons immediately after kidney procurement. The parameters are based on the aspects of a kidney upon inspection by the procurement surgeon and could be observed or measured during retrieval. The organ assessment form was set up by a procurement surgeon and a nephrologist and modified after consultation with other procurement surgeons. The form was tested by all regional organ procurement surgeons for feasibility and accuracy.This study included all kidneys from deceased donors that were retrieved by the organ procurement team of the Erasmus MC, University Medical Center, Rotterdam, The Netherlands, during the period studied. There was no selection process for inclusion. During the procurement procedure, all kidneys included were scored based on the scoring system (Table 1). Variable scorings were intended to be inde-pendent of donor age.Forms were assigned and collected centrally by nurses from the regional procurement team. The temperatures at explantation and at packaging were measured with an infrared thermometer in a standardized manner. The maximum length and width of the kidney were measured with a flexible ruler. Cold ischemic time was defined as the time between the start of cold perfusion in the donor and the start of the warm ischemia time in the recipient.
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Table 1. Donor organ assessment variablesVariable Type Unit Scoring systemTemperature at extraction scale ° CTemperature at packaging scale ° CQuality perfusion scale n/a extent of decoloration of the parenchyma(1 = poor, 10 = excellent)1    2    3    4    5    6    7    8    9    10Aspect perfusate scale n/a aspect perfusate after procurement on the bench(1 = bloody, 10 = clear)1    2    3    4    5    6    7    8    9    10Quality parenchyma scale n/a quality of the parenchyma (independently of factors such as age)(1 = poor, 10 = excellent)1    2    3    4    5    6    7    8    9    10Parenchymal abnormalities nominal n/a cysts (yes/no), size, numberscarring (yes/no)parenchymal tears (yes/no)other abnormalities (yes/no)Atherosclerosis of the origo of the renal artery scale n/a extent of atherosclerosis of the origo of the renal artery(not in relation to age) (1 = none, 10 = extensive)1    2    3    4    5    6    7    8    9    10Atherosclerosis of the renal artery scale n/a extent of atherosclerosis of the renal artery >0.5 cm distal from the origo(1 = none, 10 = extensive)1    2    3    4    5    6    7    8    9    10Atherosclerosis of the aorta scale n/a (not in relation to age)(1 = none, 10 = extensive)1    2    3    4    5    6    7    8    9    10Plasticity of the renal artery scale n/a plasticity of the renal artery >0.5 cm distal from the origo(by palpation) (1 = rigid, 10 = very flexible)1    2    3    4    5    6    7    8    9    10 Degree of stenosis in the origin renal artery % degree of stenosis of the origo of the renal artery1. <50%2. 50–75%3. >75%Artery and vein abnormalities nominal n/aOverall quality of the left kidney scale n/a overall quality of the left kidney(1 = very poor, 10 = excellent)1    2    3    4    5    6    7    8    9    10 Overall quality of the right kidney scale n/a overall quality of the right kidney(1 = very poor, 10 = excellent)1    2    3    4    5    6    7    8    9    10 Kidney length scale cmKidney width scale cm
4Eur Surg Res
Tierie et al.: Assessment of Deceased-Donor Kidneys as a Predictor of Short-Term 
Transplant Outcomes
www.karger.com/esr
© 2019 The Author(s). Published by S. Karger AG, BaselDOI: 10.1159/000501602
The first warm ischemic time was defined as the time between circulatory arrest in the donor and the start of the cold perfusion, which is only applicable to donation after circulatory death (DCD). The second warm ischemic time was defined as the time from the moment the kidney was taken from ice until recircu-lation in the recipient (anastomosis time). This is applicable to both donation after brain death (DBD) and DCD.From each donor, anonymous data were retrieved from the Eurotransplant database. This data included: age, BMI, weight of the donor, length of the donor, sex, cause of death, DBD versus DCD, cardiac arrest, hypo-tensive episodes, CMV IgG status, smoking, creatinine values, alcohol abuse, hypertension, and diabetes mellitus. Furthermore, the KDRI score was calculated as a means of comparison [10].For follow-up, data on the anonymous recipients were collected from European transplant centers based on the recipient number. Age, sex, cold and warm ischemic times, maximum PRA, creatinine at 3 months and at 1 year, graft survival, patient survival, and graft function were added to the database. The measured creatinine was recalculated to the estimated glomerular filtration rate (eGFR) with the Cockcroft-Gault formula as a method to assess graft function [11]. Graft function was scored as IGF, DGF, or primary PNF. DGF was defined as the need for hemodialysis in the first week after transplantation. IGF was compared to either DGF or PNF. A second analysis was performed studying 1-year graft function. Patients with a 1-year eGFR > 50 mL/min/1.73 m2 were compared to patients with graft failure, PNF, and/or an eGFR < 50 mL/min/1.73 m2. This cut-off point was chosen so that 2 comparable groups could be obtained. In this study the aim is to predict short-term outcomes, and therefore patients with IGF are compared to patients with DGF and PNF. All analyses were performed using Statistical Package for the Social Sciences 21.0.0.1 (IBM Corporation, USA). Two-sided p < 0.05 were considered statistically significant. The tests used to evaluate differences between populations were: a 2-tailed independent samples t test, a χ2 test, and the Mann-Whitney U test.
ResultsIn this study, 90 donors donated 178 kidneys, 166 of which were transplanted at 24 different European transplant centres across The Netherlands, Belgium, Germany, Hungary, and Austria. Table 2 shows the descriptive statistics of donor, recipient, procurement, and follow-up variables. In total, 10 different procurement surgeons filled out the organ assessment forms. Twelve kidneys, from 9 different donors, were declined based on presumed bad quality. Those rejected kidneys were significantly more often from a donor of an older age (65 ± 13 vs. 54 ± 14 years; p = 0.031) and a lower BMI (22 ± 4 vs. 25 ± 5; p = 0.026). The quality of the parenchyma was worse (7.5 vs. 8.3; p = 0.014) and there was significantly more atheroscle-rosis in the aorta (6.5 ± 2.6 vs. 4 ± 2.5; p = 0.002), in the renal artery origo (5.2 ± 2 vs. 3.1 ± 2.2; p = 0.004), and in the renal artery (4.8 ± 3.2 vs. 2 ± 1.6; p < 0.001).There were 92 kidneys with IGF, 57 with DGF, and 8 with PNF. In Table 3, the variables were analyzed for prevalence of graft function (IGF vs. DGF or PNF). In this analysis, low diuresis in the donor and having a DCD donor were significantly more frequent in patients with DGF or PNF. A period of hypotension occurred significantly more often in the population with IGF (Table 3). The length and width of the kidney were significantly greater in the DGF-or-PNF group than in the IGF group. In addition, the quality of the perfusion as assessed by the procurement surgeon was significantly better in IGF group than in the DGF-or-PNF group. Finally, there was no significant difference in KDPI/KDRI score between the DGF-or-PNF group and the IGF group.In the univariate binary logistic regression analysis, the only variables with a significant influence on IGF versus DGF-or-PNF grafts were: donor weight (p = 0.050), donor BMI (p = 0.048), DCD or DBD donor (p = 0.028), hypotensive episodes (p = 0.004), quality of perfusion (p = 0.032), kidney length (p = 0.010), and kidney width (p = 0.041).
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In the multivariable analysis, the only variables with a significant influence on IGF versus DGF or PNF were quality of perfusion (p = 0.003, Exp[B] = 2.211; 95% CI 1.310–3.733) and kidney width (p = 0.010, Exp[B] = 0.530, 95% CI 0.327–0.860). A worse decoloration of the kidney was associated with decreased chances of IGF. With an increased kidney width, the chances for IGF diminished. All other variables in Table 2 lacked influence on short-term graft function in multivariable analysis.A second analysis of the 1-year graft function was performed (Table 3). A 1-year eGFR > 50 (n = 67) was compared to graft failure, PNF, and/or an eGFR < 50 (n = 57). In comparison to the population with an eGFR > 50, the population with graft failure, PNF, and/or an eGFR 
Table 2. General characteristics and variables of the donors and recipientsUnit n Mean (range) SD PercentageDonors (n = 90)Age years 90 55 (6–77) 14.5BMI 90 25 (14–48) 5Weight kg 90 76 (24–140) 20Height cm 90 173 (121–202) 11Gender % female 50 55.6DCD vs. DBD 50 55.6Cardiac arrest % 33 36.7Hypotensive episode % 20 22.2Smoking % 57 63.3Pack years years 14 (0–60) 16Creatinine (first measurement) µmol/L 75 (36–138) 23Creatinine (lowest value) µmol/L 62 (33–128) 19Diuresis mL/h 160 (15–490) 107Diuresis (last h) mL/h 140 (3–540) 110Diabetes mellitus % 6 6.7Alcohol abuse % 9 10Hypertension % 20 22.2CMV IgG+ % 45 50Recipients Age years 83 55 (3–79) Gender % female 57 31.7Maximum PRA % 14 (0–98) 26Procurement variablesCold ischemic time min 781 (93–2,134) 268Warm ischemic time 1 min 9 (0–21) 7.6Warm ischemic time 2 min 23 (14–96) 13.5Temperature at explantation ° C 20.1 (12.5–27.6) 3.1Temperature at packaging ° C 15 (3.5–22.5)Kidney length cm 11.4 (8–16) 1.4Kidney width cm 5.9 (4–9) 0.9Follow-upCreatinine at 3 months µmol/L 155 (48–579) 71.5Creatinine at 1 year µmol/L 142 (47–317) 48.9Graft survival after 1 year % 89Patient survival after 1 year % 94Donor assessment scoreKDRI 90 1.34 (0.61–2.39) 0.41KDPI % 90 70 (3–100) 24.6
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Table 3. Analysis of variables in the IGF and DGF-or-PNF groups and analysis of the 1-year graft function
IGF (n = 92) DGF (n = 57)  or PNF (n = 8) 2-sidedp value 1-year eGFR>50(n = 67) Graft failure,  PNF, or eGFR <50 (n = 57) 2-sidedp value
Donor variablesAge 53±16 56±11 0.229 50±14 61±8 0.000BMI 25±5 26±5 0.054 26±5 24±4 0.000Female sex 55 54 0.486 46 72 0.003Weight 75±17 81±22 0.060 84±20 67±14 0.000Height 173±10 174±12 0.602 177±1 169±8 0.000Smoking 62 60 0.479 75 51 0.009Pack years 13±15 13.3±16 0.931 16±14 12±16 0.205Creatinine (first measure) 75±23 73±21 0.559 79±25 68±17 0.007Creatinine (lowest value) 60±19 64±18 0.272 60±20 61±18 0.673Diuresis (first measure) 177±117 140±91 0.039 172±116 145±84 0.151Diuresis (last h) 152±118 132±106 0.298 162±128 125±86 0.082Diabetes mellitus 5 9 0.528 5 9 0.470Alcohol abuse 9 11 0.784 12 9 0.770Hypertension 18 29 0.127 18 33 0.062CMV IgG+ 45 62 0.051 52 49 0.857DBD 52 34 0.034 46 37 0.362Cardiac arrest 39 31 0.313 37 37 1.000Hypotensive episode 29 10 0.003 22 19 0.825Cause of death (CVA) 58 42 0.872 40 54 0.117KDRI 1.3±0.4 1.4±0.4 0.390 1.1±0.3 1.5±0.4 0.000KDPI 0.7±0.3 0.7±0.2 0.146 0.6±0.2 0.8±0.2 0.000
Recipient variables Age 56±13 55±14 0.741 55±12 57±14 0.274Female sex 35 32 0.864 34 33 0.907% PRA maximum 11±21 17±31 0.158 12±23 8±21 0.330
Procurement variablesCold ischemic period 753±240 806±298 0.244 767±295 765±247 0.976Warm ischemic period 1 (DCD) 14±4 15±4 0.174 8±8 10±7 0.250Warm ischemic period 2 (DBD) 35±16 32±10 0.485 34±14 33±15 0.883Warm ischemic period 2 (DCD) 33±11 33.6±14 0.817 35±10 33±15 0.694Temperature at explantation 20±3 20.5±3 0.205 20±4 20±3 0.569Temperature at packaging 15±4 15±4 0.79 15±4 15±3 0.656
Organ variablesKidney length 11.1±1.3 11.8±1.5 0.008 12±1 11±1 0.000Kidney width 5.8±0.9 6.1±0.9 0.036 6±1 6±1 0.076Plasticity of the renal artery 8±3 8±3 0.177 8±3 8±3 0.096Quality of of perfusion 9±1 8±1 0.037 8±1 9±1 0.253Aspect perfusion 8±2 8±2 0.757 8±2 9±1 0.126Artherosclerosis of the aorta 4±3 4±2 0.101 4±3 4±3 0.593Atherosclerosis at the renal artery origin 3±2 3±2 0.141 3±2 4±3 0.178Quality of the parenchyma 8±1 8±1 0.457 8±1 8±1 0.676Artherosclerosis of the renal artery 2±2 2±2 0.329 2±2 3±2 0.172Overal quality of the left kidney 8±1 8±1 0.627 9±1 8±2 0.314Overal quality of the right kidney 8±1 8±1 0.778 8±1 8±1 0.983Parenchymal abnormalities 71 72 0.483 69 67 0.813Blood vessel abnormalities 60 57 0.423 58 56 0.816Cysts 7 6 0.556 8 6 0.616Values are presented as means ± SD or percents.
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< 50 had: an older donor age, more females, a lower donor BMI and body weight, a shorter donor height, less smokers, and a lower first measured serum creatinine. Regarding the procurement variables, the size of the kidney was significantly higher.Univariate binary logistic regression analysis of the 1-year graft function resulted in 9 vari-ables with a significant influence, i.e., donor sex (p = 0.003), donor age (p = 0.000), donor height (p = 0.000), donor weight (p = 0.000), donor smoking (p = 0.007), first measured creatinine (p = 0.010), kidney length (p = 0.000), KDPI (p = 0.000), and IGF versus DGF and PNF (p = 0.041).Multivariable binary regression analysis showed a significant influence of the first measured donor creatinine (p = 0.008, Exp[B] 0.965; 95% CI 0.938–0.994), KDRI (p = 0.000, Exp[B] 70.703; 95% CI 11.947–418.417), IGF versus DGF and PNG (p = 0.019, Exp[B] 0.274; 95% CI 0.089–0.847), and kidney length (p = 0.000, Exp[B] 0.428; 95% CI 0.254–0.720) on the 1-year graft function, while all other variables remained nonsignificant.
DiscussionOur study shows that the organ procurement surgeon is able to predict short-term trans-plant outcomes. At procurement, the kidney size is larger and the decoloration score of a graft is lower in kidneys with DGF or PNF compared to IGF. This influence was confirmed in our multi-variable binary regression analysis, demonstrating that decoloration matters. A plausible expla-nation is that these kidneys might be insufficiently washed out, or even congested, which may predispose to DGF. DGF is associated with short-term complications, comorbidity, and a reduction of the 1-year graft survival [12, 13]. This results in a lower quality of life and a poor prognosis for the recipient [14, 15]. Although kidneys from DCD donors are known to have significantly higher rates of DGF [16, 17], early recognition of kidneys prone to DGF may improve graft and patient survival in transplanted patients. These DGF kidneys might benefit from recon-ditioning strategies, such as machine perfusion [16]. In our analysis, the influence on long-term graft survival was confirmed but KDRI did not predict the short-term graft survival. Zens et al. [17] confirmed that in 2018 as DCD kidneys had higher DGF rates than their DBD counterparts but in DCD kidneys, a higher KDPI score did not significantly affect the DGF rates.The 1-year renal function was remarkably fair in our population. In order to obtain comparable groups, a fair function was defined as an eGFR > 50 mL/min. In our multivariable binary regression analysis on the 1-year graft function, the variables that significantly influ-enced the prevalence of PNF, graft failure, or eGFR < 50 were: KDRI, DGF, donor serum creat-inine, and kidney length. This means that the short-term graft function and 1-year graft function are indeed influenced by different variables. The long-term graft function is predicted by the known variables that are included in donor risk scores as discussed in the Introduction, but the short-term function is predicted by other factors. The length and width of the explanted kidney and quality of perfusion expressing congestion of the kidney significantly influence the chance of PNF or DGF. As the short-term graft function largely influences patient survival in the direct postoperative phase, a predictive index might lead to preventive measures as reconditioning strategies.There are several limitations to this study. This was a single-center study initially, but kidneys were transported to multiple centers in the Eurotransplant district. From some transplantations data were lacking because these were not collected or delivered by the centers where the transplantation procedures had taken place. Another limitation is the rela-tively small size of the study. Preferably, the groups with DGF and PNF would have been analyzed separately, but the small size of the PNF group did not allow for a separate analysis.The assessment was done by the procurement surgeons and is a subjective measurement. Different procurement surgeons participated in gathering the data, which was partially based 
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on a ranking scale. In spite of this and in spite of the relatively small dataset, quality of perfusion and kidney size were significantly different in the populations with good versus bad short-term graft functions. This supports our hypothesis that the “subjective impression” of the surgeon relies on the observation of the degree of congestion and kidney size, together with the quality of perfusion. In univariate and multivariable analyses, the variable procurement surgeon did not influence the outcome. In conclusion, poorly perfused kidneys would probably benefit most from reconditioning strategies, such as machine perfusion. A scoring system incorporating these surgical details could be helpful in the allocation process of ECD kidneys or in decision-making about recon-ditioning strategies such as machine perfusion. Being able to identify kidneys that might benefit from machine perfusion might increase short-term and long-term transplantation results and decrease short-term transplantation complications. Further research is indicated to determine the precise impact of a surgeon’s view on the donor organ. 
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